Segment Information (Tables)

9 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Schedule of segment performance measures

Nine Months Ended March 31, 2016 and 2015:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated  Corporate			Consolidated Totals
2016
Net sales	$	175,306	$	118,496	$	129,298	$	-		$	423,100
Gross profit		61,172		20,870		26,696		-			108,738
Income (loss) before income taxes		29,927		8,389		13,776		(8,472	)		43,620
2015
Net sales	$	160,808	$	111,104	$	128,452	$	-		$	400,364
Gross profit		50,829		19,750		23,689		-			94,268
Income (loss) before income taxes		21,096		5,393		9,925		(4,658	)		31,756

Three Months Ended March 31, 2016 and 2015:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated  Corporate			Consolidated Totals
2016
Net sales	$	58,780	$	45,841	$	53,305	$	-		$	157,926
Gross profit		19,125		8,648		10,516		-			38,289
Income (loss) before income taxes		8,630		4,608		6,972		(4,666	)		15,544
2015
Net sales	$	56,305	$	40,548	$	48,943	$	-		$	145,796
Gross profit		19,957		6,674		9,967		-			36,598
Income (loss) before income taxes		8,667		1,533		5,105		(1,679	)		13,626